Author
Listed:
- Elad Jacoby
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Present address: Department of Pediatric Hematology and Oncology, The Edmond and Lily Safra’s Children’s Hospital, Sheba Medical Center, and Sackler School of Medicine, Tel Aviv University, Israel.)
- Sang M. Nguyen
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Thomas J. Fountaine
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Kathryn Welp
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Berkley Gryder
(Genetics Branch, National Cancer Institute, National Institutes of Health)
- Haiying Qin
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Yinmeng Yang
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Christopher D. Chien
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Alix E. Seif
(The Children’s Hospital of Philadelphia, Perelman School of Medicine of the University of Pennsylvania)
- Haiyan Lei
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Young K. Song
(Genetics Branch, National Cancer Institute, National Institutes of Health)
- Javed Khan
(Genetics Branch, National Cancer Institute, National Institutes of Health)
- Daniel W. Lee
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Crystal L. Mackall
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Rebecca A. Gardner
(Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, University of Washington)
- Michael C. Jensen
(Ben Towne Center for Childhood Cancer Research, Seattle Children’s Hospital, University of Washington)
- Jack F. Shern
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
- Terry J. Fry
(Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health)
Abstract
Adoptive immunotherapy using chimeric antigen receptor (CAR) expressing T cells targeting the CD19 B lineage receptor has demonstrated marked success in relapsed pre-B-cell acute lymphoblastic leukaemia (ALL). Persisting CAR-T cells generate sustained pressure against CD19 that may drive unique mechanisms of resistance. Pre-B ALL originates from a committed pre-B cell or an earlier progenitor, with potential to reprogram into other hematopoietic lineages. Here we report changes in lineage markers including myeloid conversion in patients following CD19 CAR therapy. Using murine ALL models we study the long-term effects of CD19 CAR-T cells and demonstrate partial or complete lineage switch as a consistent mechanism of CAR resistance depending on the underlying genetic oncogenic driver. Deletion of Pax5 or Ebf1 recapitulates lineage reprogramming occurring during CD19 CAR pressure. Our findings establish lineage switch as a mechanism of CAR resistance exposing inherent plasticity in genetic subtypes of pre-B-cell ALL.
Suggested Citation
Elad Jacoby & Sang M. Nguyen & Thomas J. Fountaine & Kathryn Welp & Berkley Gryder & Haiying Qin & Yinmeng Yang & Christopher D. Chien & Alix E. Seif & Haiyan Lei & Young K. Song & Javed Khan & Daniel, 2016.
"CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity,"
Nature Communications, Nature, vol. 7(1), pages 1-10, November.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12320
DOI: 10.1038/ncomms12320
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Azucena Ramos & Catherine E. Koch & Yunpeng Liu-Lupo & Riley D. Hellinger & Taeyoon Kyung & Keene L. Abbott & Julia Fröse & Daniel Goulet & Khloe S. Gordon & Keith P. Eidell & Paul Leclerc & Charles A, 2023.
"Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening,"
Nature Communications, Nature, vol. 14(1), pages 1-21, December.
- Guillem Pascual-Pasto & Brendan McIntyre & Margaret G. Hines & Anna M. Giudice & Laura Garcia-Gerique & Jennifer Hoffmann & Pamela Mishra & Stephanie Matlaga & Simona Lombardi & Rawan Shraim & Patrick, 2024.
"CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma,"
Nature Communications, Nature, vol. 15(1), pages 1-19, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms12320. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.